The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...
In a victory for Robert F. Kennedy Jr.’s “MAHA” agenda, panelists narrowly recommended broader use of four peptides despite a ...
The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results